These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33373824)

  • 1. Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients.
    Dillenburg Weiss TL; Gössling G; Venzon Antunes M; Schwartsmann G; Linden R; Gasparin Verza S
    J Pharm Biomed Anal; 2021 Feb; 195():113861. PubMed ID: 33373824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients.
    Bhatnagar A; McKay MJ; Thaysen-Andersen M; Arasaratnam M; Crumbaker M; Gurney H; Molloy MP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121741. PubMed ID: 31421381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivatives.
    Caron P; Turcotte V; Lévesque E; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():249-255. PubMed ID: 30537624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in human plasma.
    Weiss TLD; Furtado CM; Antunes MV; Gössling G; Schwartsmann G; Linden R; Verza SG
    Biomed Chromatogr; 2020 Nov; 34(11):e4947. PubMed ID: 32652651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An LC-MS/MS method for quantification of the active abiraterone metabolite Δ(4)-abiraterone (D4A) in human plasma.
    van Nuland M; Rosing H; de Vries J; Ovaa H; Schellens JHM; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():119-124. PubMed ID: 29059586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application.
    da Silva LC; Grando AP; de Baco LS; Hahn RZ; Ferreira Filho AF; Brucker N; Linden R; Antunes MV
    J Pharm Biomed Anal; 2023 Oct; 235():115539. PubMed ID: 37517245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
    Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate.
    Takahashi Y; Narita S; Shiota M; Miura M; Kagaya H; Kashima S; Yamamoto R; Nara T; Huang M; Numakura K; Saito M; Eto M; Habuchi T
    Eur J Clin Pharmacol; 2023 Jan; 79(1):89-98. PubMed ID: 36378297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
    Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry.
    Bhatnagar A; McKay MJ; Crumbaker M; Ahire K; Karuso P; Gurney H; Molloy MP
    J Pharm Biomed Anal; 2018 May; 154():66-74. PubMed ID: 29533860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of clozapine and norclozapine in dried plasma spot and dried blood spot by liquid chromatography-tandem mass spectrometry.
    Carniel E; Dos Santos KA; de Andrade de Lima L; Kohlrausch R; Linden R; Antunes MV
    J Pharm Biomed Anal; 2022 Feb; 210():114591. PubMed ID: 35033943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
    Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
    Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects.
    Hu Y; Wu J; Jiang X; Chen G; Zhang Y; Si L; Jiang H; Huang J; Huang J
    J Pharm Biomed Anal; 2022 Aug; 217():114826. PubMed ID: 35576735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully Automated Dried Blood Spot Extraction coupled to Liquid Chromatography-tandem Mass Spectrometry for Therapeutic Drug Monitoring of Immunosuppressants.
    Deprez S; Stove CP
    J Chromatogr A; 2021 Sep; 1653():462430. PubMed ID: 34384960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.
    Knapen LM; Beer Y; Brüggemann RJM; Stolk LM; Vries F; Tjan-Heijnen VCG; Erp NPV; Croes S
    J Pharm Biomed Anal; 2018 Feb; 149():106-113. PubMed ID: 29112898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
    Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of polymyxin B in dried blood spots using LC-MS/MS for therapeutic drug monitoring.
    Huang X; Liu X; Wang Y; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123131. PubMed ID: 35149368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of ribociclib in dried blood spots by LC-MS/MS: Method development and clinical validation.
    Braal CL; Lam MH; Rienks T; van Tilborg CJ; Heuts W; Heijns JB; Bos MEMM; Mathijssen RHJ; de Bruijn P; Koolen SLW
    J Pharm Biomed Anal; 2021 Jul; 201():114118. PubMed ID: 34000578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.